These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17331982)

  • 1. NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies.
    Köhr G
    J Physiol; 2007 May; 581(Pt 1):1-2. PubMed ID: 17331982
    [No Abstract]   [Full Text] [Related]  

  • 2. [NMDA receptor antagonists: a new treatment for neuropathic pain].
    Pud D; Eisenberg E
    Harefuah; 1999 Apr; 136(7):564-7. PubMed ID: 15532603
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of memantine.
    Johnson JW; Kotermanski SE
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract]   [Full Text] [Related]  

  • 5. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
    Gilling KE; Jatzke C; Hechenberger M; Parsons CG
    Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor antagonists and pain: ketamine.
    Muir WW
    Vet Clin North Am Equine Pract; 2010 Dec; 26(3):565-78. PubMed ID: 21056300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.
    Hillhouse TM; Negus SS
    Eur J Pain; 2016 Sep; 20(8):1229-40. PubMed ID: 26914635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?
    Smith PF
    Curr Opin Investig Drugs; 2003 Jul; 4(7):826-32. PubMed ID: 14619404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
    Krystal JH
    Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
    [No Abstract]   [Full Text] [Related]  

  • 11. The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia.
    Henriksson KG; Sörensen J
    Rheum Dis Clin North Am; 2002 May; 28(2):343-51. PubMed ID: 12122922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA Receptors as Potential Therapeutic Targets in Diabetic Nephropathy: Increased Renal NMDA Receptor Subunit Expression in Akita Mice and Reduced Nephropathy Following Sustained Treatment With Memantine or MK-801.
    Roshanravan H; Kim EY; Dryer SE
    Diabetes; 2016 Oct; 65(10):3139-50. PubMed ID: 27388219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroprotective effect of N-methyl-D-aspartate receptor antagonists in an experimental glaucoma model in the rat].
    Gu Z; Yamamoto T; Kawase C; Matsubara M; Kawase K; Sawada A; Kitazawa Y
    Nippon Ganka Gakkai Zasshi; 2000 Jan; 104(1):11-6. PubMed ID: 10659620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients.
    Pickering G; Pereira B; Morel V; Tiberghien F; Martin E; Marcaillou F; Picard P; Delage N; de Montgazon G; Sorel M; Roux D; Dubray C
    Contemp Clin Trials; 2014 Jul; 38(2):314-20. PubMed ID: 24948402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glutamate antagonists for treatment of neuropathic pain].
    Block F; Habermeyer B
    Schmerz; 2003 Aug; 17(4):261-7. PubMed ID: 12923675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of magnesium ions on the regulation of NMDA receptor--a pharmacopathology of memantine].
    Kato T
    Clin Calcium; 2004 Aug; 14(8):76-80. PubMed ID: 15577101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
    Cauli O; Rodrigo R; Boix J; Piedrafita B; Agusti A; Felipo V
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G503-11. PubMed ID: 18599589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral NMDA receptors revisited - Hope floats.
    Carlton SM
    Pain; 2009 Nov; 146(1-2):1-2. PubMed ID: 19767145
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo.
    Shafton AD; Bogeski G; Kitchener PD; Sanger GJ; Furness JB; Shimizu Y
    Neurogastroenterol Motil; 2007 Jul; 19(7):617-24. PubMed ID: 17539896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.